Clik here to view.
Merck Finds Potent China Partner in Simcere 默克牵手先声药业
US drug giant Merck (NYSE: MRK) has become the latest major pharmaceuticals company to pair up with a Chinese partner, in this case US-listed Simcere Pharmaceutical (NYSE: SCR), in a bid to take...
View ArticleClik here to view.
Rongyao’s US Lawsuit Spotlights China’s Lack of PR Savy *荣耀高调起诉辉瑞 彰显公司缺乏公关意识
I wanted to start today with a report that shows that Chinese firms need some serious education in how to do good public relations and, equally important, need to understand when NOT to embark on...
View ArticleClik here to view.
China Patent Move Highlights Healthcare Risk 医改东风可借 药企切莫贪婪无度
Global drug makers like Merck (NYSE: MRK) and Bristol-Myers (NYSE: BMY) have been piling into China’s drug market over the last few years in a bid to take advantage of huge new opportunities presented...
View ArticleClik here to view.
Medtronic Swallows Kanghui, More M&A on Tap?
I’ve written lots about the huge potential that China offers for drug makers as Beijing rolls out a multibillion-dollar reform of the country’s medical system. But there’s also huge potential for...
View ArticleNews Digest: November 3 报摘： 2012年11月3日
The following press releases and media reports about Chinese companies were carried on November 3-5. To view a full article or story, click on the link next to the...
View ArticleNews Digest: May 3-5, 2014
The following press releases and media reports about Chinese companies were carried on May 3-5. To view a full article or story, click on the link next to the headline....
View ArticleChina News Digest: June 29, 2016
The following press releases and news reports about China companies were carried on June 29. To view a full article or story, click on the link next to the headline....
View Article
